<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00981981</url>
  </required_header>
  <id_info>
    <org_study_id>GIL8034</org_study_id>
    <nct_id>NCT00981981</nct_id>
  </id_info>
  <brief_title>Effect of the Molecular Weight of Oat β-glucan on Its Ability to Lower Serum Cholesterol</brief_title>
  <acronym>Bluebird</acronym>
  <official_title>Effect of Varying Dose and Molecular Weight on the Serum LDL-cholesterol-lowering Properties of Oat β-glucan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glycemic Index Laboratories, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CreaNutrition, AG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Guelph</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Sydney</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Reading Scientific Services Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Agriculture and Agri-Food Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Glycemic Index Laboratories, Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purposes of this study were:

        1. To determine if a breakfast cereal containing 3g of high molecular weight oat
           beta-glucan fiber would lower low-density lipoprotein (LDL) - cholesterol (the &quot;bad&quot;
           cholesterol) compared to a control cereal containing wheat fiber.

        2. To determine if the LDL-cholesterol-lowering effect of oat beta-glucan fiber was reduced
           when the molecular weight of the fiber was reduced.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The FDA allows a health claim that oat products may reduce the risk of heart disease, based
      on meta-analyses showing a cholesterol-lowering effect of oat beta-glucan, if the product
      delivers at least a 3g daily dose of oat beta-glucan. However, not all studies have
      demonstrated a lowering of oat products. This may be due to variable bioactivity of the
      beta-glucan in the oat products. The bioactivity of oat beta-glucan is believed to depend
      upon its viscosity in the gut. Factors influencing viscosity include the molecular weight
      (MW) of the beta-glucan molecule and the amount of soluble beta-glucan in the product, which,
      in turn determines its concentration (C) in solution. In finished food products both MW and C
      can be modified by beta-glucanase enzymes present in other ingredients in the food (eg. wheat
      flour), processing (eg. extrusion) and storage (eg. freezing of moist products such as
      muffins). The effect of altering the MW and solubility of beta-glucan in foods on glycemic
      responses has been shown, but a role for MW and C in cholesterol lowering has not been
      established.

      To address this issue, this study was designed with 2 primary objectives:

        1. An extruded oat cereal containing 3g high-molecular weight oat β-glucan daily will
           reduce LDL cholesterol compared to a control wheat bran cereal.

        2. A significant correlation exists between LDL cholesterol and log(C×MW), where C is the
           amount of soluble β-glucan in the daily dose of cereal and MW is the molecular weight of
           the β-glucan in the cereal.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum LDL-cholesterol lowering effect of 3g high MW beta-glucan</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation between serum LDL-cholesterol lowering and log(MW*C)</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum triglycerides</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum HDL cholesterol</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting serum glucose</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum aspartate transaminase</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum c-reactive protein</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum urea</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum creatinine</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time course of changes in blood lipids</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Macronutrient composition of diet</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms questionnaire</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>apolipoprotein B</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum markers of cholesterol absorption and synthesis</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">367</enrollment>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Wheat bran cereal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3g high MW</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cereal containing 3g high molecular weight oat beta glucan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4g medium MW</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cereal containing 4g oat beta glucan with medium molecular weight</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3g medium MW</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cereal containing 3g oat beta glucan with medium molecular weight</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4g low MW</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cereal containing 4g oat beta glucan with low molecular weight</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Wheat bran</intervention_name>
    <description>21g per day of ready to eat breakfast cereal containing wheat bran with 8g of total dietary fiber and 0.5g beta-glucan.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>3g high MW</intervention_name>
    <description>20.2 grams per day of ready to eat cereal containing 6g total dietary fiber and 3g oat beta glucan with high molecular weight</description>
    <arm_group_label>3g high MW</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>4g medium MW</intervention_name>
    <description>28.5g ready to eat cereal containing 8g total dietary fiber and 4g oat beta glucan with medium molecular weight</description>
    <arm_group_label>4g medium MW</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>3g medium MW</intervention_name>
    <description>21.1g of ready to eat cereal containing 6g total fiber and 3g oat beta glucan with a medium molecular weight</description>
    <arm_group_label>3g medium MW</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>4g low MW</intervention_name>
    <description>28.7g ready to eat cereal containing 8g total dietary fiber and 4g oat beta glucan with low molecular weight</description>
    <arm_group_label>4g low MW</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  body mass index 18.5 to 40.0 kg/m^2

          -  no intention to lose or gain weight

          -  fasting total cholesterol 5.0 to 8.0 mmol/L

          -  fasting LDL cholesterol 3.0 to 5.0 mmol/L

          -  consuming diet containing &lt;15% energy from saturated fat

        Exclusion Criteria:

          -  use of any cholesterol-lowering drug, herbal or nutritional supplement

          -  regular consumption of oatmeal, oat bran or psyllium - containing cereals

          -  fasting serum triglycerides &gt;4.0mmol/L

          -  serum aspartate transaminase &gt;1.5 times upper limit of normal

          -  serum urea or creatinine &gt;1.8 times upper limit of normal

          -  presence of diabetes or fasting glucose &gt;6.9mmol/L

          -  presence or recent major surgical or medical event

          -  allergy to wheat or oats

          -  presence of condition or drug which alters digestion or absorption of foods
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas MS Wolever, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glycemic Index Laboratories, Inc</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter J Wood, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Agriculture and Agri-Food Canada</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Susan M Tosh, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Agriculture and Agri-Food Canada</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alison L Gibbs, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Statistics, University of Toronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SUGiRS Human Nutrition Unit, School of Molecular &amp; Microbial Biosciences, Unviersity of Sydney</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2006</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Human Nutraceutical Research Unit, Department of Human Health and Nutritional Sciences, University of Guelph</name>
      <address>
        <city>Guelph</city>
        <state>Ontario</state>
        <zip>N1G 2W1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glycemic Index Laboratories, Inc.</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5C 2X3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nutraceuticals and Functional Foods Institute, Faculte des science de l'agriculture et de l'alimentation, Universite Laval</name>
      <address>
        <city>Laval</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Reading Scientific Services, Ltd (RSSL)</name>
      <address>
        <city>Reading</city>
        <state>Berkshire</state>
        <zip>RG6 6LA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>United Kingdom</country>
  </location_countries>
  <results_reference>
    <citation>Wolever TM, Tosh SM, Gibbs AL, Brand-Miller J, Duncan AM, Hart V, Lamarche B, Thomson BA, Duss R, Wood PJ. Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial. Am J Clin Nutr. 2010 Oct;92(4):723-32. doi: 10.3945/ajcn.2010.29174. Epub 2010 Jul 21.</citation>
    <PMID>20660224</PMID>
  </results_reference>
  <results_reference>
    <citation>Tosh SM, Brummer Y, Miller SS, Regand A, Defelice C, Duss R, Wolever TM, Wood PJ. Processing affects the physicochemical properties of beta-glucan in oat bran cereal. J Agric Food Chem. 2010 Jul 14;58(13):7723-30. doi: 10.1021/jf904553u.</citation>
    <PMID>20527967</PMID>
  </results_reference>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2009</study_first_submitted>
  <study_first_submitted_qc>September 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2009</study_first_posted>
  <last_update_submitted>June 20, 2011</last_update_submitted>
  <last_update_submitted_qc>June 20, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 21, 2011</last_update_posted>
  <responsible_party>
    <name_title>Thomas MS Wolever, President</name_title>
    <organization>Glycemic Index Laboratories, Inc.</organization>
  </responsible_party>
  <keyword>humans</keyword>
  <keyword>randomized clinical trial</keyword>
  <keyword>dietary fiber</keyword>
  <keyword>nutrition</keyword>
  <keyword>beta-glucan</keyword>
  <keyword>oats</keyword>
  <keyword>LDL cholesterol</keyword>
  <keyword>coronary heart disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

